Related Experiment Video
Updated: Jun 21, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
RSV Prevention Within Reach for Older Infants and Toddlers: The Role of Active Immunization
Asuncion Mejias1,2, Octavio Ramilo1,2
1Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Insights
New vaccines and monoclonal antibodies are being evaluated to prevent respiratory syncytial virus (RSV) disease in young children. This review covers passive immunity for infants and active immunization strategies using various vaccine types.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in infants and young children.
- Current prevention strategies are limited, highlighting the need for novel interventions.
Purpose of the Study:
- To review current vaccines and monoclonal antibodies under investigation for RSV prevention in young children.
- To discuss the scientific rationale for passive and active immunization against RSV.
Main Methods:
- Literature review of ongoing clinical trials and research on RSV prevention.
- Analysis of different vaccine platforms including live attenuated, protein-based, and mRNA vaccines.
- Evaluation of monoclonal antibodies for passive protection.
Main Results:
- Several promising vaccines and monoclonal antibodies are in development for RSV.
- Passive immunization offers protection in early infancy, while active immunization targets older children.
- Diverse vaccine technologies are being explored for efficacy and safety.
Conclusions:
- Multiple novel strategies are emerging for RSV prevention in pediatric populations.
- A combination of passive and active immunization may be necessary for comprehensive RSV control.
- Continued research is crucial to bring these preventative measures to fruition.
Abstract:
This review article will summarize the vaccines and monoclonal antibodies currently under evaluation for the prevention of RSV disease in older infants, toddlers and young children. We will review the rationale for passive protection during the first months of life, and the role of active immunization afterwards, either with live attenuated, protein-based or mRNA vaccines.
More Related Videos
Related Concept Videos
Vaccinations
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

